Evidence map›Paper›PMID 32567385›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2020

The effects of cardiac drugs on human erythrocyte carbonic anhydrase I and II isozymes.

Onur Argan, Kübra Çıkrıkçı, Aybike Baltacı, Nahit Gencer

Open access · goldAbstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Hidden targets in dermatology:Journal of enzyme inhibition and medicinal chemistry · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Onur ArganDepartment of Cardiology, Faculty of Medicine, Balikesir University, Balikesir, Turkey.ORCID http://orcid.org/0000-0001-7745-7736
Kübra ÇıkrıkçıDepartment of Chemistry, Science and Art Faculty, Balikesir University, Balikesir, Turkey.ORCID http://orcid.org/0000-0003-2276-1516
Aybike BaltacıDepartment of Chemistry, Science and Art Faculty, Balikesir University, Balikesir, Turkey.ORCID http://orcid.org/0000-0003-1185-7336
Nahit GencerDepartment of Chemistry, Science and Art Faculty, Balikesir University, Balikesir, Turkey.ORCID http://orcid.org/0000-0001-7092-8857
Balıkesir University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular diseases are the leading cause of mortality worldwide. In recent years, the relationship between carbonic anhydrase inhibitors and atherosclerosis has attracted attention. In this study, we aimed to determine the

Indexed as

AcetazolamideCarbonic Anhydrase ICarbonic Anhydrase IICarbonic Anhydrase InhibitorsChromatography, AffinityErythrocytesHumansAcetazolamideCarbonic Anhydrase ICarbonic Anhydrase IICarbonic Anhydrase Inhibitorscarbonic anhydraseCardiac drugsenzyme inhibition

Identifiers

PMID32567385
PMCPMC7717712
OpenAlexW3035921418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.